Related Experiment Video
Updated: Aug 9, 2026

Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI
Published on: July 12, 2012
Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias)
Abstract:
In this essay we first review the important contributions of Dr. George Cotzias to the understanding of chronic manganese intoxication and of manganese metabolism in man and animals. We also indicate the original contribution of Dr. John Donaldson to the mechanism of the neurotoxicity of manganese. In a second phase, the author challenges the tenet that Parkinson's disease is a form of chronic manganese intoxication and that manganism is an experimental model for Parkinson's disease. Clinical, pathological, experimental and biochemical evidence are brought to bear on this argument. Thirdly the author proposes that the necessary event to the so-called "depigmentation" of the substantia nigra and subsequent bradykinetic "low dopamine" syndrome is an early enhanced turnover of dopamine. Manganese intoxication is only one of the factors which may serve as a trigger to this event. Many others are also listed. In opposition to current views, who look for causal factors in Parkinson's disease along the pathways for melanogenesis, the author thus proposes a novel hypothesis which envisions a variety of transient "trigger factors" acting at the dopamine synapse to increase dopamine turnover. In turn, this increased synthesis of dopamine favours the production of large quantities of free radicals within the cell bodies in the substantia nigra, eventually overflowing the scavenging capacity of neuromelanin and their protective barrier, and causing cell death. The resulting decreased pool of dopamine-producing cells leads to a self-perpetuating situation of ever increasing demand on the remaining cells, and "progression" of the disease. Finally the author stresses the fact that genetic factors may play a role in an individual's susceptibility to such triggers. Again defective manganese transport, metabolism or binding are only some of the mechanisms possibly underlying such genetic predisposition to induced basal ganglia disorders. Further studies relating to manganese in these disorders and particularly in Parkinson's disease should focus not on the "intoxication" part of the overload and its striatopallidal consequences, but on the intimate mechanism of destabilization of the homeostatic regulator in neuromelanin bearing cells, even after the exposure period.
Insights
Parkinson's disease is not caused by manganese intoxication. Instead, dopamine turnover triggers cell death, with manganese being just one potential factor. Genetic susceptibility also plays a role in developing basal ganglia disorders.
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- Reviews contributions of George Cotzias and John Donaldson on manganese toxicity and metabolism.
- Challenges the established view of Parkinson's disease (PD) as chronic manganese intoxication.
- Manganism is questioned as an experimental model for PD.
Purpose of the Study:
- To critically evaluate the link between manganese intoxication and Parkinson's disease.
- To propose a novel hypothesis for the pathogenesis of Parkinson's disease.
- To explore the role of dopamine turnover and free radical production in neurodegeneration.
Main Methods:
- Clinical, pathological, experimental, and biochemical evidence review.
- Hypothesis formulation based on dopamine synapse function.
- Analysis of neuromelanin's role in free radical scavenging.
Main Results:
- Manganese intoxication is presented as one of many potential triggers for enhanced dopamine turnover.
- Increased dopamine synthesis leads to free radical overproduction, causing cell death in the substantia nigra.
- This cell death results in a self-perpetuating cycle of dopamine deficiency and disease progression.
Conclusions:
- Parkinson's disease pathogenesis involves enhanced dopamine turnover, not solely manganese intoxication.
- Transient trigger factors destabilize dopamine homeostasis, leading to neurodegeneration.
- Genetic predisposition influences susceptibility to these triggers and the development of basal ganglia disorders.
More Related Videos
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry (CE-ICP-MS) for Quantification of Iron Redox Species (Fe(II), Fe(III))
Published on: May 4, 2020
06:17Quantifying Levels of Dopaminergic Neuron Morphological Alteration and Degeneration in Caenorhabditis elegans
Published on: November 20, 2021
Related Concept Videos
Drugs that Stabilize Microtubules
Lysosomal Hydrolases
Drugs that Destabilize Microtubules
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll